0 Comments
0 Shares
1123 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Ankylosing Spondylitis (AS) Involves Inflammation And Chronic Inflammation Of The SpineAnkylosing Spondylitis Treatment can also assist to postpone or prevent the spine from fusing and hardening. If there is non-radiographic axial spondyloarthritis, these therapies may be beneficial. Non-operative treatments are usually helpful in addressing the symptoms of Ankylosing Spondylitis. Non-surgical options include pain medicines and physical therapy. However, if spondylosis has caused...0 Comments 0 Shares 1346 Views 0 Reviews
- Ankylosing Spondylitis (AS) Market Research Report and Competitive AnalysisThe Ankylosing Spondylitis (AS) Market provides in-depth analysis of global, regional and country-level markets, segmentation growth, market share, competitive landscape, sales analysis, impact of global and domestic Ankylosing Spondylitis (AS) Market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth...0 Comments 0 Shares 1009 Views 0 Reviews
- Ankylosing Spondylitis (AS) Market Size, Share, Key Players, Growth Trend, and Forecast, 2022–2027Report and Data has recently published a global Ankylosing Spondylitis (AS) Market research report that offers a comprehensive assessment of the market size, market share, revenue growth, top companies, and revenue forecast for 2022-2027. The continuously rising geriatric population, the rise in the incidence rate of ankylosing spondylitis and the elevating focus on R&D activities...0 Comments 0 Shares 1921 Views 0 Reviews
- Ankylosing Spondylitis Drugs Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2028The rise in the incidence rate of ankylosing spondylitis, the elevating focus on R&D activities, and lack of approval of therapies have resulted in boosting the Ankylosing Spondylitis Drugs market. The global ankylosing spondylitis drugs market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data. Ankylosing...0 Comments 0 Shares 2179 Views 0 Reviews
- Ankylosing Spondylitis Drugs Market Trend Scenario, Growth Strategies and Forecast 2028The global ankylosing spondylitis drugs market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data. Ankylosing spondylitis (AS) can be described as a type of arthritis, which is not commonly observed among the patients of arthritis. The condition results in stiffness and pain in the spine. It is a chronic condition, which usually begins with...0 Comments 0 Shares 1242 Views 0 Reviews
- Ankylosing Spondylitis Market Recent Trends, Growth Analysis 2023The global ankylosing spondylitis market size was valued at USD 5,460.5 million in 2022 and is poised to grow at a significant CAGR of 4.8% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....0 Comments 0 Shares 950 Views 0 Reviews
- Anterior Lumbar Interbody Fusion Research Report: Global Industry Analysis, Size, Share, Growth, Trends and Forecast By 2028The study carried out in Anterior Lumbar Interbody Fusion (ALIF) Market report spans heterogeneous markets in accord with the requirement of Anterior Lumbar Interbody Fusion (ALIF) Market industry and scoop out the best possible solutions and meticulous information about the market trends. This Anterior Lumbar Interbody Fusion (ALIF) Market report employs the use of latest tools and techniques...0 Comments 0 Shares 1108 Views 0 Reviews
- Humira Biosimilar Market is Anticipated to Witness High Growth Owing to Patent Expiry of Reference DrugThe humira biosimilar market consists of biosimilar versions of the reference biologic drug Humira (adalimumab). Humira is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and others. The introduction of biosimilar versions of Humira provides a more cost effective treatment...0 Comments 0 Shares 566 Views 0 Reviews